Page 173 - Read Online
P. 173

Israël. J Cancer Metastasis Treat 2019;5:12                         Journal of Cancer
               DOI: 10.20517/2394-4722.2018.78                           Metastasis and Treatment




               Review                                                                        Open Access


               Metabolic rewiring of stem cells and differentiated
               cells in cancer: the hypothetical consequences of a

               GABA deficiency in endocrine pancreas


               Maurice Israël


               Institut Alfred Fessard, Centre National de la Recherche Scientifique, 2 Av. Terrasse, 91190 Gif sur Yvette, France.

               Correspondence to: Dr. Maurice Israël, Institut Alfred Fessard, Centre National de la Recherche Scientifique, 2 Av. Aristide
               Briand, 91440 Bures sur Yvette, France. E-mail: mauisrael@wanadoo.fr

               How to cite this article: Israël M. Metabolic rewiring of stem cells and differentiated cells in cancer: the hypothetical consequences
               of a GABA deficiency in endocrine pancreas. J Cancer Metastasis Treat 2019;5:12.
               http://dx.doi.org/10.20517/2394-4722.2018.78

               Received: 22 Nov 2018    First Decision: 21 Dec 2018     Revised: 14 Jan 2019    Accepted: 16 Jan 2019    Published: 27 Feb 2019


               Science Editor: Rafat Siddiqui    Copy Editor: Cai-Hong Wang    Production Editor: Huan-Liang Wu





               Abstract
               The carcinogenic mechanism proposed considers that stem cells committed to repair tissues and differentiated
               cells, acquire different metabolic properties, if there is an associated GABA deficiency suppressing a control
               system of the endocrine pancreas. This control system mediated by GABA, released with insulin, normally turns off
               glucagon and somatostatin release when insulin is released. A consequence of the GABA deficiency in pancreas
               and adrenals is a hybrid insulin-glucagon-somatostatin message, received by new mitotic stem cells displaying
               then a hybrid metabolic rewiring. This gives them a selective metabolic advantage over differentiated cells that
               become insulin resistant and only receive the glucagon- somatostatin part of the hormonal message. Indeed, their
               insulin receptors are desensitized by the persistent leakage of insulin resulting from the GABA deficiency that fails
               to close the insulin release mechanism. Thus differentiated cells are simply rewired to be plundered by stem cells.
               The metabolic advantage gained by stem cells blocks their own differentiation and maintains their mitotic capacity.
               Inevitable mutations of mitotic cells follow, the immune system is unable to eliminate a geometrically increasing
               number of altered stem cells, a selection of the most aggressive but metabolically successful population takes place
               when cancer is declared.




                           © The Author(s) 2019. Open Access This article is licensed under a Creative Commons Attribution 4.0
                           International License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use,
                sharing, adaptation, distribution and reproduction in any medium or format, for any purpose, even commercially, as long
                as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license,
                and indicate if changes were made.


                                                                                                                                                  www.jcmtjournal.com
   168   169   170   171   172   173   174   175   176   177   178